The Anti-Inflammatory Activity of a Novel Fused-Cyclopentenone Phosphonate and Its Potential in the Local Treatment of Experimental Colitis

A novel fused-cyclopentenone phosphonate compound, namely, diethyl 3-nonyl-5-oxo-3,5,6,6a-tetrahydro-1H-cyclopenta[c]furan-4-ylphosphonate (P-5), was prepared and tested in vitro (LPS-activated macrophages) for its cytotoxicity and anti-inflammatory activity and in vivo (DNBS induced rat model) for...

Full description

Saved in:
Bibliographic Details
Main Authors: Dorit Moradov, Helena Shifrin, Efrat Harel, Mirela Nadler-Milbauer, Marta Weinstock, Morris Srebnik, Abraham Rubinstein
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2015/939483
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565254577455104
author Dorit Moradov
Helena Shifrin
Efrat Harel
Mirela Nadler-Milbauer
Marta Weinstock
Morris Srebnik
Abraham Rubinstein
author_facet Dorit Moradov
Helena Shifrin
Efrat Harel
Mirela Nadler-Milbauer
Marta Weinstock
Morris Srebnik
Abraham Rubinstein
author_sort Dorit Moradov
collection DOAJ
description A novel fused-cyclopentenone phosphonate compound, namely, diethyl 3-nonyl-5-oxo-3,5,6,6a-tetrahydro-1H-cyclopenta[c]furan-4-ylphosphonate (P-5), was prepared and tested in vitro (LPS-activated macrophages) for its cytotoxicity and anti-inflammatory activity and in vivo (DNBS induced rat model) for its potential to ameliorate induced colitis. Specifically, the competence of P-5 to reduce TNFα, IL-6, INFγ, MCP-1, IL-1α, MIP-1α, and RANTES in LPS-activated macrophages was measured. Experimental colitis was quantified in the rat model, macroscopically and by measuring the activity of tissue MPO and iNOS and levels of TNFα and IL-1β. It was found that P-5 decreased the levels of TNFα and the tested proinflammatory cytokines and chemokines in LPS-activated macrophages. In the colitis-induced rat model, P-5 was effective locally in reducing mucosal inflammation. This activity was equal to the activity of local treatment with 5-aminosalicylic acid. It is speculated that P-5 may be used for the local treatment of IBD (e.g., with the aid of colon-specific drug platforms). Its mode of action involves inhibition of the phosphorylation of MAPK ERK but not of p38 and had no effect on IκBα.
format Article
id doaj-art-b426785f3fa048e69c895506d97bda68
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-b426785f3fa048e69c895506d97bda682025-02-03T01:08:54ZengWileyGastroenterology Research and Practice1687-61211687-630X2015-01-01201510.1155/2015/939483939483The Anti-Inflammatory Activity of a Novel Fused-Cyclopentenone Phosphonate and Its Potential in the Local Treatment of Experimental ColitisDorit Moradov0Helena Shifrin1Efrat Harel2Mirela Nadler-Milbauer3Marta Weinstock4Morris Srebnik5Abraham Rubinstein6Faculty of Medicine, School of Pharmacy Institute for Drug Research, The Hebrew University of Jerusalem, P.O. Box 12065, 91120 Jerusalem, IsraelFaculty of Medicine, School of Pharmacy Institute for Drug Research, The Hebrew University of Jerusalem, P.O. Box 12065, 91120 Jerusalem, IsraelFaculty of Medicine, School of Pharmacy Institute for Drug Research, The Hebrew University of Jerusalem, P.O. Box 12065, 91120 Jerusalem, IsraelFaculty of Medicine, School of Pharmacy Institute for Drug Research, The Hebrew University of Jerusalem, P.O. Box 12065, 91120 Jerusalem, IsraelFaculty of Medicine, School of Pharmacy Institute for Drug Research, The Hebrew University of Jerusalem, P.O. Box 12065, 91120 Jerusalem, IsraelFaculty of Medicine, School of Pharmacy Institute for Drug Research, The Hebrew University of Jerusalem, P.O. Box 12065, 91120 Jerusalem, IsraelFaculty of Medicine, School of Pharmacy Institute for Drug Research, The Hebrew University of Jerusalem, P.O. Box 12065, 91120 Jerusalem, IsraelA novel fused-cyclopentenone phosphonate compound, namely, diethyl 3-nonyl-5-oxo-3,5,6,6a-tetrahydro-1H-cyclopenta[c]furan-4-ylphosphonate (P-5), was prepared and tested in vitro (LPS-activated macrophages) for its cytotoxicity and anti-inflammatory activity and in vivo (DNBS induced rat model) for its potential to ameliorate induced colitis. Specifically, the competence of P-5 to reduce TNFα, IL-6, INFγ, MCP-1, IL-1α, MIP-1α, and RANTES in LPS-activated macrophages was measured. Experimental colitis was quantified in the rat model, macroscopically and by measuring the activity of tissue MPO and iNOS and levels of TNFα and IL-1β. It was found that P-5 decreased the levels of TNFα and the tested proinflammatory cytokines and chemokines in LPS-activated macrophages. In the colitis-induced rat model, P-5 was effective locally in reducing mucosal inflammation. This activity was equal to the activity of local treatment with 5-aminosalicylic acid. It is speculated that P-5 may be used for the local treatment of IBD (e.g., with the aid of colon-specific drug platforms). Its mode of action involves inhibition of the phosphorylation of MAPK ERK but not of p38 and had no effect on IκBα.http://dx.doi.org/10.1155/2015/939483
spellingShingle Dorit Moradov
Helena Shifrin
Efrat Harel
Mirela Nadler-Milbauer
Marta Weinstock
Morris Srebnik
Abraham Rubinstein
The Anti-Inflammatory Activity of a Novel Fused-Cyclopentenone Phosphonate and Its Potential in the Local Treatment of Experimental Colitis
Gastroenterology Research and Practice
title The Anti-Inflammatory Activity of a Novel Fused-Cyclopentenone Phosphonate and Its Potential in the Local Treatment of Experimental Colitis
title_full The Anti-Inflammatory Activity of a Novel Fused-Cyclopentenone Phosphonate and Its Potential in the Local Treatment of Experimental Colitis
title_fullStr The Anti-Inflammatory Activity of a Novel Fused-Cyclopentenone Phosphonate and Its Potential in the Local Treatment of Experimental Colitis
title_full_unstemmed The Anti-Inflammatory Activity of a Novel Fused-Cyclopentenone Phosphonate and Its Potential in the Local Treatment of Experimental Colitis
title_short The Anti-Inflammatory Activity of a Novel Fused-Cyclopentenone Phosphonate and Its Potential in the Local Treatment of Experimental Colitis
title_sort anti inflammatory activity of a novel fused cyclopentenone phosphonate and its potential in the local treatment of experimental colitis
url http://dx.doi.org/10.1155/2015/939483
work_keys_str_mv AT doritmoradov theantiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT helenashifrin theantiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT efratharel theantiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT mirelanadlermilbauer theantiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT martaweinstock theantiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT morrissrebnik theantiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT abrahamrubinstein theantiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT doritmoradov antiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT helenashifrin antiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT efratharel antiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT mirelanadlermilbauer antiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT martaweinstock antiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT morrissrebnik antiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis
AT abrahamrubinstein antiinflammatoryactivityofanovelfusedcyclopentenonephosphonateanditspotentialinthelocaltreatmentofexperimentalcolitis